drugset / Trial / NCT00732693

Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure

NCT00732693 ↗

Phase 4 Completed 42 enrolled University of Edinburgh
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study is to determine whether physiological sex steroid replacement improves parameters of skeletal, cardiovascular and reproductive health of women treated with current sex steroid replacement regimens.

Timeline

Start
2002-02
Primary completion
2006-11
Completion
2006-11

Outcome

Mixed primary results

paper There was a greater estimated mean ET with the use of pSSR (4.8 mm) compared to that with standard therapy (3.0 mm) PMID 22343553 ↗

paper with an estimated difference of 1.8 mm [95% confidence interval (CI), 0.7 to 2.8, P=0.002] PMID 22343553 ↗

paper estimated difference of 4.2 cm(3) (95% CI -0.4 to 8.7) was not statitsically significant, P=0.070. PMID 22343553 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 150 ug Other
Subject Norethindrone Unknown 1.5 mg Oral
Subject Progesterone Other / unclassified 200 mg Other
Subject ethinyl estradiol Small molecule 30 ug Oral